Description
EXERCISE OPTION Y2 - MOD DECREASE
Base award description: LEASE OF ORTHO VISION AND REAGENTS
Modification chain · 17 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$214,990= $214,990
- Mod P000012022-12-08-$244= $214,746
- Mod P000022023-08-01+$0= $214,746
- Mod P000032023-10-01+$214,378= $429,124
- Mod P000042023-12-13+$406= $429,530
- Mod P000072024-08-07+$720= $430,250
- Mod P000082024-08-29+$0= $430,250
- Mod P000052024-10-01-$8,024= $422,226
- Mod P000092024-10-01+$214,233= $636,459
- Mod P000102024-11-12-$1,082= $635,377
- Mod P000112025-05-23-$6,918= $628,459
- Mod P000122025-05-23+$0= $628,459
- Mod P000132025-10-01+$220,757= $849,216
- Mod P000142025-10-28+$0= $849,216
- Mod P000152026-03-24-$2,908= $846,308
- Mod P000162026-04-07-$7,773= $838,535
- Mod P000172026-09-02+$0= $838,535
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$214,990 | $214,990 | LEASE OF ORTHO VISION AND REAGENTS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-08 | −$244 | $214,746 | CORRECT LINE ITEM 3 PRICING, REDUCE ITEM 16 AND ADD ITEM 33 OF REAGENTS |
| Mod P00002· EXERCISE AN OPTION | 2023-08-01 | +$0 | $214,746 | EXERCISE OPTION 1 |
| Mod P00003· EXERCISE AN OPTION | 2023-10-01 | +$214,378 | $429,124 | BLOOD ANALYZERS EXERCISE OPTION 1 |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-13 | +$406 | $429,530 | BLOOD ANALYZERS CHANGE QUANTITIES OF SEVERAL DUE TO CHANGE IN GOV'T NEEDS |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-08-07 | +$720 | $430,250 | BLOOD ANALYZERS CHANGE QUANTITIES OF SEVERAL DUE TO CHANGE IN GOV'T NEEDS |
| Mod P00008· EXERCISE AN OPTION | 2024-08-29 | +$0 | $430,250 | BLOOD ANALYZERS OY 2 RENEWAL |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-10-01 | −$8,024 | $422,226 | DECREASE EXCESS FUNDS FOR FY23 PO. |
| Mod P00009· FUNDING ONLY ACTION | 2024-10-01 | +$214,233 | $636,459 | BLOOD ANALYZERS OY 2 FUNDING |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-12 | −$1,082 | $635,377 | CORRECT PRICE AND QTY OF BLOOD ANALYZERS |
| Mod P00011· OTHER ADMINISTRATIVE ACTION | 2025-05-23 | −$6,918 | $628,459 | DE-OBLIGATION FOR CLOSEOUT 614C40097 |
| Mod P00012· OTHER ADMINISTRATIVE ACTION | 2025-05-23 | +$0 | $628,459 | DE-OBLIGATION FOR CLOSEOUT 614C40097 |
| Mod P00013· EXERCISE AN OPTION | 2025-10-01 | +$220,757 | $849,216 | EXERCISE OPTION Y3 |
| Mod P00014· OTHER ADMINISTRATIVE ACTION | 2025-10-28 | +$0 | $849,216 | EXERCISE OPTION Y3 |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-03-24 | −$2,908 | $846,308 | EXERCISE OPTION Y3 |
| Mod P00016· OTHER ADMINISTRATIVE ACTION | 2026-04-07 | −$7,773 | $838,535 | EXERCISE OPTION Y2 - MOD DECREASE |
| Mod P00017· FUNDING ONLY ACTION | 2026-09-02 | +$0 | $838,535 | EXERCISE OPTION Y2 - MOD DECREASE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZFXRG96JMJ39)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N0813 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $126,199 | FY2026 |
| 36C24426N0812 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $106,952 | FY2026 |
| 36C24426N0811 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $9,494 | FY2026 |
| 36C24426A0042 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C25026N0609 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $16,220 | FY2026 |
| 36C25526N0312 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,363 | FY2026 |
Other recipients under 6640 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926P0515 | BRANCH MEDICAL LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $134,799 | FY2026 |
| 36C24926N0641 | DIASORIN INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $172,138 | FY2026 |
| 36C24926P0473 | TERUMO BCT BIOTECHNOLOGIES, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $16,420 | FY2026 |
| 36C24926P0421 | CREATIVE WASTE SOLUTIONS, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $35,433 | FY2026 |
| 36C24926P0425 | STRIPES GLOBAL, INC. | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $23,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24923F0034_3600_V797D60637_3600 · retrieved 2026-09-26.